Alan Kwan builds companies around technology worth owning.
Australian born and working across Hong Kong, Australia and China, he is a co-founder of The Super Group, the private family office and the technology company it built. He is Chairman of BOSA Technology Holdings, a technology company he has chaired since 2017 and through its listing on the Hong Kong Stock Exchange in 2018, where he also chairs the Nomination Committee and sits on the Audit Committee. He is a director of Bionic Vision Technologies, the Australian company developing a bionic eye to restore sight to people living with inherited blindness, and a principal of State Path Capital, the Hong Kong investment company behind its US$18 million funding.
His early career was spent in mining and property development, and in building enterprise IT systems in Singapore, where over thirteen years as Executive Director of JMC Technologies he led the build of a digitisation platform whose payment and wallet systems were certified by the Monetary Authority of Singapore. He has since served as Chairman and Chief Executive of AL Group, an interior design and fit-out company listed in Hong Kong, and is a director and the largest shareholder of PepCap Resources, listed on the TSX Venture Exchange. He holds a Bachelor of Science, a Master of Health Science and a Graduate Diploma in Law.
His method is the same in every company he builds. Identify defensible intellectual property. Bring the capital and the relationships to commercialise it. Build it into a listed, enduring company. It is the thinking that took BOSA to its Hong Kong listing, and the thinking he now applies to one of the most ambitious medical technologies of the decade.
